Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Sustainability Profile
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, commonly known as Bidiphar, is a prominent player in the pharmaceutical and medical equipment industry, headquartered in Binh Dinh, Vietnam. Established in 1977, Bidiphar has consistently evolved, marking significant milestones in its journey towards becoming a trusted name in healthcare. The company focuses on the production and distribution of high-quality pharmaceuticals, medical devices, and healthcare products, catering to both domestic and international markets. Bidiphar's commitment to innovation and quality sets it apart, with a diverse portfolio that includes prescription medications, over-the-counter drugs, and advanced medical equipment. With a strong market position, Bidiphar has garnered recognition for its contributions to public health and has established a reputation for reliability and excellence in the industry.
DitchCarbon Score
How does Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's reported carbon emissions
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented reduction targets or climate commitments available from the company. As of now, Binh Dinh Pharmaceutical has not established any science-based targets or climate pledges, nor does it inherit emissions data from a parent company or corporate family. This lack of data suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the broader context of the pharmaceutical and medical equipment industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious climate goals. Binh Dinh Pharmaceutical may benefit from aligning with industry standards and best practices to enhance its sustainability efforts in the future.
How Carbon Intensive is Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's Industry?
How Carbon Intensive is Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's Location?
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
